RxDoctor Payments Data

Gina Looney

Family · Royston, GANPI 1548714512

Payments from drug & device makers

$558in general payments, 2019–2025

Across 30 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$166
  • Exact Sciences$130
  • Novo Nordisk$88
  • Pfizer$68
  • Biohaven Pharmaceutical Holding Company Ltd.$29
  • AbbVie$25
  • plus $54 from 3 others

What the payments were for

  • Food & beverage$558100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$558 in reported general payments places this provider in the 55th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$2,642
Medicare patients
64
Services billed
241

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide94$126,184
OzempicSemaglutide81$98,135
EliquisApixaban116$93,317
LinzessLinaclotide71$56,041
TrulicityDulaglutide39$52,308
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$48,592
XareltoRivaroxaban52$34,931
JanuviaSitagliptin Phosphate15$25,979
Combivent RespimatIpratropium/Albuterol Sulfate24$15,254
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog28$13,777
SymbicortBudesonide/Formoterol Fumarate43$10,485
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$8,554
Albuterol Sulfate HfaAlbuterol Sulfate265$7,179
Tresiba Flextouch U-200Insulin Degludec13$7,086
Diclofenac Sodium92$6,615

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$166$178,493133 claims
Novo NordiskOzempic$88$98,13581 claims
PfizerEliquis$68$93,317116 claims
AbbVieLinzess$25$56,04171 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 6,258 family providers in Georgia.

Other family in Royston

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →